Cryotherapy Market Size, Share, Outlook, and Opportunity Analysis, 2021 – 2028
- Get link
- X
- Other Apps
Cryotherapy Market |
Cryotherapy,
often known as cold treatment or icepack therapy, is a technique for removing
tissue or nerve lesions and curing diseases like cervical cancer,
retinoblastoma, and skin cancer. Patients are also given ice baths to help ease
and relax body areas affected by muscular strains, tissue damage, or prolonged
exercise. The cold causes blood vessels to tighten, reducing the quantity of
inflammatory cytokines that reach the location, resulting in excruciating
agony. Different gases, such as argon and nitrogen, are employed in cryotherapy
treatments. Cryoprobes, which are used to treat primary tumours and
malignancies in cancer, administer liquid nitrogen directly to the targeted
sites. Cryosurgery has the advantage of being less unpleasant and having a less
intrusive technique, resulting in a speedier recovery and a lesser risk of
infection transmission.
Increasing product launches and
affordable cryotherapy devices are projected to boost the cryotherapy market
growth during the forecast period
Increasing
product introductions, low-cost cryotherapy devices, and rising cryotherapy
device use are projected to drive Cryotherapy
Market growth
throughout the forecast period. CryoBuilt, Inc., a developer of whole body
cryotherapy systems, for example, introduced EVEREST, an innovative and
inexpensive product range of whole body cryotherapy chambers in May 2020.
EVEREST chambers cool with fresh oxygenated cold air, so there's no possibility
of toxic gas exposure. The EVEREST line of chambers from CryoBuilt, Inc. allows
users to take full control of the system using the company's CryoBrain app.
Rising collaboration activities among
key market players is a major factor that is expected to drive the cryotherapy
market growth during the forecast period
Collaborations
are projected to drive market expansion throughout the forecast period,
according to key industry competitors. For example, in May 2019, Medtronic Plc,
an American-Irish registered medical device firm, partnered with Koninklijke
Philips N.V., a healthcare technology corporation based in Amsterdam. This
collaboration is expected to result in an integrated, cutting-edge image guided
solution for cryoablation. This procedure is for the advanced treatment of
paroxysmal atrial fibrillation, a common cardiac rhythm problem. Key market
players' company development strategies are likely to take the worldwide
cryotherapy market forward.
- Get link
- X
- Other Apps
Comments
Post a Comment